転移性骨腫瘍
WordNet
- remove the bones from; "bone the turkey before roasting it" (同)debone
- the porous calcified substance from which bones are made (同)osseous_tissue
- consisting of or made up of bone; "a bony substance"; "the bony framework of the body"
- a shade of white the color of bleached bones (同)ivory, pearl, off-white
- rigid connective tissue that makes up the skeleton of vertebrates (同)os
- having bones as specified; "his lanky long-boned body"
- having had the bones removed; "a boneless rib roast"; "a boned (or deboned) fish" (同)deboned
- a percussion instrument consisting of a pair of hollow pieces of wood or bone (usually held between the thumb and fingers) that are made to click together (as by Spanish dancers) in rhythm with the dance (同)castanets, clappers, finger cymbals
- relating to or affected by metastasis; "metastatic growth"
- an abnormal new mass of tissue that serves no purpose (同)tumour, neoplasm
PrepTutorEJDIC
- 〈C〉骨 / 〈U〉骨を作っている物質,骨質 / 《複数形で》骨格;死骸(がい) / 〈魚など〉‘の'骨を取る
- (魚など)骨を取り除いた / (衣服が)(コルセットなどで)骨で張りをつけた[ような]
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- The chemotherapeutic drug boanmycin induces cell senescence and senescence-associated secretory phenotype factors, thus acquiring the potential to remodel the tumor microenvironment.
- Chen P1, Guo H, Chen J, Fu Y.
- Anti-cancer drugs.Anticancer Drugs.2016 Feb;27(2):84-8. doi: 10.1097/CAD.0000000000000304.
- Boanmycin hydrochloride, a new antitumor agent, functions similarly to bleomycin, but has a shorter half-life and faster clearance in vivo. Therefore, it is used in clinical studies for lung squamous cell cancer. However, previous studies have shown that besides its antitumor effect, bleomycin also
- PMID 26460847
- The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?
- Li R1, Zhang K, Penedo TL, Kragel CP, Grizzle WE, Hameed O, Siegal GP, Wei S.
- Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry.Appl Immunohistochem Mol Morphol.2016 Jan;24(1):42-50. doi: 10.1097/PAI.0000000000000151.
- Receptor activator of NF-κB (RANK) and its ligand, RANKL, are essential for osteoclastogenesis and modulate osteolytic bone metastasis. The RANKL/RANK system is also fundamental for mammary gland development and plays a potential role in breast carcinogenesis. c-Src, a nonreceptor tyrosine kinase d
- PMID 26200837
- A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
- Fong EL1, Wan X2, Yang J2, Morgado M3, Mikos AG1, Harrington DA3, Navone NM4, Farach-Carson MC5.
- Biomaterials.Biomaterials.2016 Jan;77:164-72. doi: 10.1016/j.biomaterials.2015.10.059. Epub 2015 Nov 9.
- Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. However, the complex in vivo environment makes it challenging to employ PDX models to investigate tumor-stromal interactions, such as those that mediate prostate cancer (PCa) bone metastasis. Thus, we
- PMID 26599623
Japanese Journal
- 股関節全置換術中に術前に診断されていなかった骨腫瘍のため大量出血を来した1症例
- 麻酔 = The Japanese journa of anesthesiology : 日本麻酔科学会準機関誌 66(2), 154-156, 2017-02
- NAID 40021088788
- Successful recovery from a subclavicular ulcer caused by lenvatinib for thyroid cancer: a case report
- 外科的に脳転移を診断しアレクチニブが著効したALK陽性肺癌の1例
Related Links
- Bone is the third most common site of metastatic disease. Cancers most likely to metastasize to bone include breast, lung, prostate, thyroid and kidney. Carcinomas are much more likely to metastasize to bone than sarcomas. The ...
- Bone is the third most common site of metastatic disease. Cancers most likely to metastasize to bone include breast, lung, prostate, thyroid and kidney. Carcinomas are much more likely to metastasize to bone than sarcomas. The ...
Related Pictures
★リンクテーブル★
[★]
- 英
- metastatic bone tumor, metastatic bone tumors
- 関
- 骨転移性癌、骨腫瘍
[★]
- 関
- metastasizing、metastatic phenotype
[★]
[★]
骨